Oncolytics Biotech (ONCY) Reports Q2 Loss of $0.03/Share

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.03), versus ($0.05) reported last year.

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• CVG to join Russell 2000 and Russell 3000 indexes June 26
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat